New‐onset autoimmune phenomena post‐COVID‐19 vaccination
Y Chen, Z Xu, P Wang, XM Li, ZW Shuai, DQ Ye… - …, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review
Y Rodríguez, M Rojas, S Beltrán, F Polo… - Journal of …, 2022 - Elsevier
Autoimmunity linked to COVID-19 immunization has been recorded throughout the
pandemic. Herein we present six new patients who experienced relapses of previous …
pandemic. Herein we present six new patients who experienced relapses of previous …
Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome
Conclusions SARS‐CoV‐2 vaccination can be associated with liver injury. Corticosteroid
therapy may be beneficial in those with immune‐mediated features or severe hepatitis …
therapy may be beneficial in those with immune‐mediated features or severe hepatitis …
Insights into new-onset autoimmune diseases after COVID-19 vaccination
M Guo, X Liu, X Chen, Q Li - Autoimmunity reviews, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …
Autoimmune hepatitis
BT Beretta-Piccoli, G Mieli-Vergani… - The Rose and Mackay …, 2024 - Elsevier
Autoimmune hepatitis (AIH) is an inflammatory liver disease, affecting mainly females,
characterized by elevated transaminase and immunoglobulin G (IgG) levels, interface …
characterized by elevated transaminase and immunoglobulin G (IgG) levels, interface …
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …
particularly healthcare professionals and patients. While the rapid development of safe and …
Autoimmune hepatitis-like syndrome following COVID-19 vaccination: a systematic review of the literature
KW Chow, NV Pham, BM Ibrahim, K Hong… - Digestive diseases and …, 2022 - Springer
Objectives During the summer of 2021, case reports began to emerge documenting a small
number of individuals who developed autoimmune hepatitis (AIH) following COVID-19 …
number of individuals who developed autoimmune hepatitis (AIH) following COVID-19 …
[HTML][HTML] COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature
L Camacho-Domínguez, Y Rodríguez, F Polo… - Journal of translational …, 2022 - Elsevier
Autoimmunity following COVID-19 vaccination has been reported. Herein, a 79-year-old
man with clinical and immunological features of autoimmune hepatitis type 1 after ChAdOx1 …
man with clinical and immunological features of autoimmune hepatitis type 1 after ChAdOx1 …
Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines
Background & Aims Case reports of severe acute liver injury (ALI) following COVID-19
vaccination have recently been published. We evaluated the risks of ALI following COVID-19 …
vaccination have recently been published. We evaluated the risks of ALI following COVID-19 …
An insight overview on COVID-19 mRNA vaccines: advantageous, pharmacology, mechanism of action, and prospective considerations
The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has urged scientists to present some novel vaccine platforms during this pandemic to …
has urged scientists to present some novel vaccine platforms during this pandemic to …